Service profile
CytoDyn Inc.
Biotechnology company developing leronlimab therapeutic antibody targeting CCR5 receptor for HIV treatment, cancer, and inflammatory conditions through clinical trial programs.
About
What CytoDyn Inc. is
Biotechnology company developing leronlimab therapeutic antibody targeting CCR5 receptor for HIV treatment, cancer, and inflammatory conditions through clinical trial programs.
losclouds keeps public details for this profile. There are no catalog offerings to compare yet.
Healthcare
At a glance
| Fact | Value |
|---|---|
| Official site | https://cytodyn.com |
| Status coverage | Public status page |
| Founded | 2002 |
| Headquarters | Vancouver, Washington, USA |
| Categories | Healthcare |
Loading offerings...